Peter Reynolds

The life and times of Peter Reynolds

Author Archive

Cruel And Irresponsible Response from UK Government To Parliamentary Report On Medicinal Cannabis.

leave a comment »

doctor-tips-bud-out-of-pot

Unsurprisingly perhaps, the response to the recent call from MPs and peers to legalise cannabis for medicinal use has come straight from the top.  Theresa May’s longstanding reputation as a denier of science and evidence on drugs policy is reinforced by her peremptory dismissal of the expert report.  It seems that, at least in the short term, the UK government is sticking by a policy that is discredited, ridiculous and deeply cruel.

It fell to Sarah Newton MP, minister of state at the Home Office, to respond to a parliamentary question from Roger Godsiff, Labour MP for Birmingham, Hall Green.

Roger Godsiff MP

Roger Godsiff MP

“To ask the Secretary of State for the Home Department, if she will respond to the recommendations of the report by the All-Party Parliamentary Group for Drug Policy Reform Accessing Medicinal Cannabis: Meeting Patients’ Needs, published in September 2016.”

 

Sarah Newton MP

Sarah Newton MP

“The Prime Minister responded to the All-Party Parliamentary Group for Drug Policy Reform’s report ‘Accessing Medicinal Cannabis: Meeting Patients’ Needs’ on the 27 October.

Cannabis is controlled as a Class B drug under the Misuse of Drugs Act 1971 and, in its raw form, currently has no recognised medicinal benefits in the UK. It is therefore listed as a Schedule 1 drug under the Misuse of Drugs Regulations 2001.

It is important that all medicines containing controlled drugs are thoroughly trialled to ensure they meet rigorous standards so that doctors and patients are sure of their efficacy and safety. To do otherwise for cannabis would amount to a circumvention of the clearly established and necessary regime for approving medicines in the UK.”

In other words, this is nothing more than a re-statement of the same position that the UK government has held since 1971 when legal access to medicinal cannabis was halted.  Quite clearly the government has given no consideration at all to the vast amount of scientific evidence and international experience that has accumulated over the last 45 years.  The latest report which took nine months to produce, took evidence from over 600 witnesses and included a review of over 20,000 scientific studies is simply cast aside.  To be honest, I doubt whether it has even been read by Ms May or anyone in the Home Office or Department of Health. This is the standard that now prevails in the UK – government of the people by an unaccountable, out-of-touch, unresponsive cabal of individuals elected by a deeply flawed system that gives democracy a bad name.

On the face of it, the claim that all medicines must be thoroughly trialled seems plausible – but it is not.  It is a misleading half-truth clearly intended to squash the call for access to medicinal cannabis by painting a false picture.

Doctors are allowed to prescribe any medicine, licensed or unlicensed, as they see fit, based on their own judgement. But prescribing of cannabis is specifically prohibited by Statutory Instrument despite the scientific consensus that it is far less dangerous than many, probably most commonly prescribed medicines.

So it’s not a level playing field.  It’s a policy that is based on prejudice and scaremongering about recreational use of cannabis.  Ms Newton’s answer is at best disingenuous but then she probably doesn’t even realise that herself.  For many years Home Office policy has been systematically to mislead and misinform on cannabis and evidently under Ms May’s successor, Amber Rudd MP, such dishonesty continues.

Theresa May MP

Theresa May MP

Something will eventually force the government’s hand to change its absurd position on cannabis. Sadly the very last consideration will be scientific evidence or the will of the people. Such factors hold no sway with  UK governments. Only when enough of the political elite open their eyes and examine their conscience, or some key individuals or their family members, experience the need for medicinal cannabis will change become possible.  Alternatively, political upheaval may present an opportunity. The Liberal Democrats were too cowardly, weak and concerned with building their personal careers when in coalition to advance the cause they now so bravely advocate.  Perhaps the SNP, with 56 MPs, all in favour of medicinal cannabis may be our best hope.

Sarah Newton is merely a puppet of the Home Office bureaucracy.  Theresa May’s mendacious position on all aspects of drugs policy is well established and she is as stubborn and bigoted as they come on such matters.  Only when she, in person, is subject to sufficient pressure will this cruel, ignorant and hateful policy change.

Guidelines On Cannabis For Medical Professionals.

with one comment

rcgp-external-hq

In a new initiative, CLEAR’s scientific and medical advisor, Professor Mike Barnes, has written to the presidents of several Royal Colleges proposing the development of guidelines around the use of cannabis as medicine.

Professor Mike Barnes

Professor Mike Barnes

This is a tricky situation for doctors.  Surveys and individual reports from CLEAR members indicate that many doctors tacitly endorse their patients’ use of cannabis but clearly cannot recommend the illegal use of cannabis, however safe and effective it may be.

Professor Barnes’ letter refers to the recent APPG report, his own paper ‘Cannabis: The Evidence for Medical Use’ and says:

“…cannabis now has a reasonable evidence base for the management of chronic pain, including neuropathic pain, and the management of spasticity as well as in the management of anxiety and a use in nausea and vomiting in the context of chemotherapy.”

In conjunction with CLEAR, Professor Barnes has written to:

Royal College of Anaesthetists
Royal College of General Practitioners
Royal College of Paediatrics and Child Health
Royal College of Physicians
Royal College of Psychiatrists

His letter goes on to explain that about one million people are using cannabis as medicine:

“I do feel that doctors need guidelines to assist them when patients request advice on the use of cannabis…doctors should be properly informed about harm reduction advice and should be aware of the clinical evidence that is now guiding medicinal use in several other countries around the world.”

Our proposal is for an initial meeting to discuss the idea.  If one or more of the Royal Colleges is prepared to back this initiative, CLEAR will set up and fund a working group of clinicians and medical education specialists to develop a set of guidelines.

 

Wise Words From Trump Supporters?

with one comment

trump-supporters

Some thoughts here that chitter-chattering, Remoaners, Remaniacs, the soft left and particularly the illiberal, anti-democratic LibDems would do well to consider.

How did this happen you ask?

You created “us” when you attacked our freedom of speech.
You created “us” when you attacked our right to bear arms.
You created “us” when you attacked our Christian beliefs.
You created “us” when you constantly referred to us as racists.
You created “us” when you constantly called us xenophobic.
You created “us” when you told us to get on board or get out of the way.
You created “us” when you forced us to buy health care and then financially penalized us for not participating.
You created “us” when you allowed our jobs to continue to leave our country.
You created “us” when you attacked our flag.
You created “us” when you confused women’s rights with feminism.
You created “us” when you began to emasculate men.
You created “us” when you decided to make our children soft.
You created “us” when you decided to vote for progressive ideals.
You created “us” when you attacked our way of life.
You created “us” when you decided to let our government get out of control.
“You” created “us” the silent majority.
And we became fed up and we pushed back and spoke up.
And we did it with ballots, not bullets.

Written by Peter Reynolds

November 11, 2016 at 8:51 am

Posted in Politics

Tagged with , , ,

I Am Not A Badge Of Honour.

leave a comment »

poppy-bw-bg

I am not a badge of honour,
I am not a racist smear,
I am not a fashion statement,
To be worn but once a year,
I am not glorification
Of conflict or of war.
I am not a paper ornament
A token,
I am more.

I am a loving memory,
Of a father or a son,
A permanent reminder
Of each and every one.

I’m paper or enamel
I’m old or shining new,
I’m a way of saying thank you,
To every one of you.

I am a simple poppy
A Reminder to you all,
That courage faith and honour,
Will stand where heroes fall.

By Paul Hunter, 2014

Written by Peter Reynolds

November 10, 2016 at 4:43 pm

Posted in What is this blog about?

Tagged with ,

Achievement Against All Odds.

leave a comment »

rich-quirky-smile-crop

I am the most fortunate of fathers.  I could never have dreamed that my children would scale such heights. A fortnight ago my youngest son, Evan, qualified as a chartered surveyor.  Today my eldest, Richard, capped his extraordinary achievement in becoming a barrister by gaining tenancy at 9, Bedford Row, possibly the top international criminal and human rights set in London.

In the 21st century, the route to success as a barrister is almost impossible to negotiate but Richard has done so despite many disadvantages and challenges.

Born five weeks premature, he spent his first days of life in the special care baby unit.  Twice-butchered, traumatised before the age of three in what should have been a minor operation at the Royal Surrey Hospital, he was at last properly served by a skilled surgeon at Great Ormond Street. Then, at the age of four, he was diagnosed with type one diabetes. His response, even as a small child, was to become an expert.  Before he was a teenager he could have taken on any doctor, any diabetician, any endocrinologist and taught them a thing or two.  His whole life is characterised by determination and an ability to gain knowledge through intense study and the application of his most remarkable intelligence.

As a child, he was known in our wider family as ‘the next prime minster but six’.  I still have no doubt that he could achieve that if he put his mind to it – and he still may. He was individual national champion in the ‘Debating Matters’ competition and then, despite dyslexia, diabetes and far from the finest secondary education, he made his way to the University of East Anglia to study politics, philosophy and economics, that degree most favoured by our leaders and the elite.  In truth, he neglected his studies for student politics, editing ‘Concrete’, the university newspaper and then launching a rival, Norwich-wide student magazine. Despite this he gained the requisite 2:1 and was by that time set on a career in the law.

Unlike many of his contemporaries at the bar, there was no silver spoon for Richard.  His mother’s hard work, the support of his grandparents and his own diligence at some depressing jobs enabled his second degree in the law and successful completion of the bar course.  To see him called at Middle Temple in October 2014 was then the proudest moment of my life, particularly as it was the very last such occasion for my father, himself a retired lawyer, before he died on the last day of that year.  I believe Richard knows what supreme joy he brought to his grandfather in those last weeks of his life.

The next stage in a barrister’s career is to gain pupillage, the essential apprenticeship that leads to a practising certificate. Fewer than one in ten who are called to the bar achieve this and often they are aided by family contacts, networks, their Oxbridge or public school connections.  Richard had none of this, only his ability, courage and a focus which makes determination an inadequate word to describe him.

I am very grateful that 9, Bedford Row granted Richard pupillage and has now given him the opportunity to reach the very top in his chosen profession.  In the year before he began pupillage he showed how much the open market already values him and was appointed General Counsel on a fat salary at TES Global, the world’s leading educational publisher.

I am in awe of my son.  He humbles me with his achievements. I have no doubt that he will take silk, become a judge, or triumph at whatever challenges he chooses.  I am the proudest father.

Written by Peter Reynolds

November 10, 2016 at 12:28 pm

CLEAR Statement Concerning Cannabis Legalisation Measures In US Election.

leave a comment »

pjr-iow

 

“This is marvellous news for liberty, health and human rights.  The USA, unlike Britain, has a functioning democracy where the will of the people prevails rather than the bigotry and self-interest of politicians.  It is wonderful to see that truth, justice and evidence is winning out over the lies and misinformation we have been fed about cannabis for almost 100 years.

In 1971, the British government abdicated all responsibility on cannabis and abandoned our communities and our children to criminal gangs.  Since then all the harms have multiplied exponentially.  The laws against cannabis fund organised crime, promote dangerous hidden farms which are fire risks, the destruction of rental property, selling to children, contaminated ‘moonshine’ cannabis, gang violence, lives ruined by criminal records and the cruel denial of safe, effective medicine that can relieve pain, suffering and disability.

Donald Trump has supported access to medicinal cannabis all along.  Many British politicians who consider him to be an unreasonable person should now look to themselves and ask whether they are being reasonable by supporting prohibition, even for medical use.

It is time for Theresa May, Amber Rudd and the UK government to take responsibility for the £6 billion pa cannabis market.  The tide of legalisation is now unstoppable and it would be deeply irresponsible for them to fail to act.  They must grasp this nettle now!”

Peter Reynolds, president of CLEAR Cannabis Law Reform

CLEAR Cannabis Law Reform Accounts 2015.

leave a comment »

Income

Compared to the previous year, CLEAR’s regular income in 2015 was up 79% to £17,074. The majority of income continues to come from memberships, with the remainder coming from donations, merchandise and Google advertising.

Regular income: £17,074

clear-income-2015

Expenditure

CLEAR spent a total of £12,023, a decrease of 11% on the previous year.

Total expenditure: £12,023

clear-expenditure-2015

Administration: membership administration, stationery, postage, telephone & internet, meeting expenses, etc. Administration costs have increased as an overall proportion of expenditure as there were no dedicated campaigns during the year.

Travel: expenses incurred meeting government ministers, MPs, agency representatives, media engagements, boards meetings, also re-imbursement of travel costs for Medicinal Use Panel members

Fundraising costs: PayPal fees and other fundraising costs

Promotion: Facebook advertising, printing of leaflets, design work, etc.

Written by Peter Reynolds

November 8, 2016 at 11:00 am

Breakfast Of Champions 2.

leave a comment »

black-pudding-omelette

A recent invention of mine.

Bake the black pudding at about 150 C for about 10 minutes.  Chop roughly and fry in butter for a few moments in the omelette pan to give crispy edges.  Add as many well-seasoned, beaten eggs as you wish and cook for a couple of minutes.  You can fold it or serve it flat and cut into sections.

Remember to give the dogs a little taste, it’s only fair.

Tip. Please keep the inside of the omelette as runny as you can, it makes all the difference.  After decades of experience as a black pudding connoisseur, I buy mine from Framptons of Bridport.  It’s described as ‘local’ but it isn’t that local because it’s made in Poole – but it is the business!

Written by Peter Reynolds

November 5, 2016 at 11:06 am

Report Of Meeting With MHRA On Regulation of Cannabidiol (CBD).

with 11 comments

Tom Whettem, Cannabidol; Anthony Cohen, Elixinol UK; Tom Rowland, CBD Oils UK; Karl Spratt, Hempire; Peter Reynolds, CLEAR Cannabis Law Reform; Mike Harlington, GroGlo Research & Development

Tom Whettem, Canabidol; Anthony Cohen, Elixinol UK; Tom Rowland, CBD Oils UK; Karl Spratt, Hempire; Peter Reynolds, CLEAR Cannabis Law Reform; Mike Harlington, GroGlo Research & Development

Yesterday, 3rd November 2016, six delegates from the UK Cannabis Trade Association (UKCTA) met with Medicines and Health Products Regulatory Agency (MHRA) representatives at the agency’s headquarters in Victoria.

We were courteously received. The meeting was cordial, productive and enabled both sides to clarify their positions and better understand each other’s perspective.

In summary, in my opinion, there is no immediate threat to to CBD consumers or businesses. The MHRA has now extended until 31 December 2016 the date by which businesses should voluntarily comply with its opinion, either by withdrawing existing products from the market, or by complying with necessary regulation. Thereafter, the next step would be to begin the process of statutory enforcement.  This would take a matter of some months and I believe, even were this to be started, we are looking at more than a year before any impact would be felt.  More importantly, based on the meeting, I think the outcome is likely to be that we can negotiate a form of regulation that will work for everyone.

The MHRA team was led by Gerald Heddell, Director of Inspection, Enforcement and Standards. Also present were regulatory advisors David Olszowska and Chris Groutides; Dr Chris Jones, Manager of the Medicines Borderline Section; Greg Markey, Senior Medical Assessor and Malcolm Evans, Head of Patient, Public and Stakeholder Engagement.  Mr Heddell opened the meeting by thanking us for bringing to the agency’s attention just how many people are using CBD, some for quite serious medical conditions.

The MHRA set out its reasons for its opinion that products containing CBD used for medical purposes are medicines.  Greg Markey explained the mechanisms of action and pharmacology that had been considered and Dr Jones explained that the Borderline Section existed to deal specifically with products where it was difficult to determine whether they should be regarded as medicines or food supplements.  The example was offered of vitamin C where if it was being used to treat scurvy then it was clearly a medicine, whereas if it was used to supplement a normal diet it could be regarded as a food supplement.  We were able to explain that all so-called CBD products on the market, with the exception of crystals, are actually whole plant extracts from low-THC cannabis, usually industrial hemp.  We pointed out that the growth in the CBD market had been driven by people seeking the therapeutic benefits of medicinal cannabis which until now had been denied by the British government.

The nub of the issue is really the nature of the condition for which CBD is used.  The MHRA has already issued orphan designations for CBD for Dravet Syndrome, graft versus host disease and perinatal asphyxia.  Orphan designations are granted where the benefit of a medicine can be recognised even though necessary regulatory processes have not yet been completed.  It is important to understand that this is what has guided the MHRA’s opinion, viewing CBD as a medicine for very serious conditions.

We discussed a range of options whereby, at the lowest level, CBD products could continue to be marketed as a food supplement.  For minor conditions, not requiring medical supervision, it may be possible to obtain a Traditional Herbal Registration (THR) at a cost of a few hundred pounds.  A third option is a ‘Specials’ exemption where a doctor or prescriber has specified and taken responsibility for an unlicensed medicine for a particular patient.  Finally, the highest level is a Marketing Authorisation (MA) where the costs including fees and clinical trials are probably a minimum of £250,000.

It is our view that CBD products should be regulated at all these different levels dependent on the purpose for which they are used and the concentration at which CBD is present.  We have agreed that we will write formally setting out these proposals and the MHRA will respond accordingly.

The UKCTA and a number of individual companies have now obtained legal advice including counsel’s opinion.  We have shared this with the MHRA and formal solicitors letters have already been served.  In essence, the advice is that the MHRA has failed to comply with its own guidelines and requirements in issuing its opinion to CBD suppliers and that any requirement to comply with regulations would have to be addressed on an individual, product by product basis.

So, all in all, we believe the meeting was a success.  We demonstrated that the new trade association is to be taken seriously and that we will work constructively with the agency.  There was visible surprise at the level of professionalism we presented, particularly with the legal advice we had obtained.  I believe we convinced the MHRA that we could establish a set of rules, guidelines and standards that would enable the industry to comply with its requirements.

The CBD market in the UK is presently worth several million pounds a year.  If it is to continue to grow, provide safe, effective products for consumers and patients and job security for its workers, then we need to establish UKCTA so that it effectively represents the whole industry.  We need to show that we are responsible, we care, we are professionals and we are ready to put our collective head above the parapet as a legal, ethical and regulated industry.

Breakfast Of Champions.

leave a comment »

kippers

I decided I deserved a treat this morning.

Kippers pan-fried in butter and a touch of olive oil, two very soft poached eggs, served with hot, buttered, granary toast and strong tea.  The dogs get a mouthful each and then are allowed to clean the plate and the pan.

Bliss.

Tip. Choose your kippers wisely, buy them from a proper fishmonger and season generously with black pepper.

Written by Peter Reynolds

November 2, 2016 at 9:46 am

Posted in Biography, food, Health

Tagged with , , ,